Net margin · 2018–2025
Catalyst Pharmaceuticals net margin
36.4%+9.2% · FY2025
Catalyst Pharmaceuticals (CPRX) reported 36.4% in net margin for fiscal 2025, +9.2% year on year.
| Fiscal year | Net margin | Change | Filing |
|---|---|---|---|
| FY2025 | 36.4% | +9.2% | Derived |
| FY2024 | 33.3% | +85.9% | Derived |
| FY2023 | 17.9% | −53.8% | Derived |
| FY2022 | 38.8% | +38.3% | Derived |
| FY2021 | 28.0% | −55.5% | Derived |
| FY2020 | 63.0% | +102.1% | Derived |
| FY2019 | 31.2% | +6,831.9 pp | Derived |
| FY2018 | −6,800.7% | — | Derived |
Net margin — Net margin is net income divided by revenue. Only companies with at least $1 billion in revenue are ranked here: a small company can post an extreme margin that tells you nothing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Calculated from two reported figures, so it has no single filing of its own.
Net margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Catalyst Pharmaceuticals net margin |url=https://companiesranked.com/en/company/catalyst-pharmaceuticals/net-profit-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Catalyst Pharmaceuticals net margin. CompaniesRanked. https://companiesranked.com/en/company/catalyst-pharmaceuticals/net-profit-marginBibTeX
@misc{companiesranked-en-company-catalyst-pharmaceuticals-net-profit-margin-2026,
author = {{CompaniesRanked}},
title = {{Catalyst Pharmaceuticals net margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/catalyst-pharmaceuticals/net-profit-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.